Feedback
Placeholder

BD MAX™ Resources

Our resource database provides you with everything you need to take your BD MAX™ to the next level

Solutions portfolio on BD MAX™ System to meet your diverse molecular testing needs

BD MAX™ System

General

BD MAX™ Molecular Diagnostic System

Molecular Workflow Optimization Service for BD MAX™ System

 

Request info

Healthcare-associated infection (HAI)

General Cdiff MRSA / StaphSR CPO

Accurate, actionable HAI diagnostics

Request info

BD MAX™ Cdiff assay leaflet

Request info

BD MAX™ MRSA assay leaflet

BD MAX™ StaphSR assay leaflet

Request info

BD MAX™ CPO assay leaflet

Request info

Gastrointestinal infection (GI)

General Bacterial Panel Parasite Panel Viral Panel

Rapid, reliable gastroenteritis diagnostics

BD MAX™ enteric brochure

Enteric Infographic

Request info

BD MAX™ Enteric Bacterial Panel leaflet

Request info

BD MAX™ Enteric Parasite Panel leaflet

Request info

BD MAX™ Enteric Viral Panel leaflet

Request info

Sexually-transmitted infection (STI)

General CT/GC/TV Vaginal Panel GBS

Targeted, efficient STI screening and diagnostics

Request info

Elevate the standard of testing by addressing the three most prevalent non-viral sexually transmitted infections

BD CTGCTV2 / BD CTGC2 for BD MAX™ System leaflet

Request info

BD MAX™ Vaginal Panel leaflet

Request info

BD MAX™ GBS assay leaflet

Request info

Respiratory tract infection (RTI)

SARS-CoV-2 / Flu / RSV General MDR-TB Others

BD Respiratory Viral panel Innovation that simplifies. Clinical differentiation that counts.

Enhancing your co-testing capabilities with versatile detection kits for the BD MAX™ System

How can you achieve MAX IMPACT in testing for COVID-19 and Flu?

Request info

Effective, timely RTI diagnostics

 

Request info

Advance the standard of testing for multi-drug-resistant tuberculosis (MDR-TB)

Request info

VIASURE Pneumocystis jirovecii Kit for BD MAX™ System leaflet

VIASURE Bordetella Kit for BD MAX™ System leaflet

Ready to take your diagnostic potential to new heights?

Contact us

Access all BD MAX™ IFUs

Secure the most up-to-date BD MAX™ user’s manuals.

Discover

Decontamination guide

for BD MAX™ System

Spain


Technical service email

SAT-BD@bd.com
IB-IDS-CSP.Support@bd.com

Technical service number

+34 918488173 

Italy


Technical service email

TSC@bd.com
dspecialisti@bd.com

Technical service number

+39 02 4824 0600

France


United Kingdom


Technical service email

BDUK_Technical_Service@bd.com

Technical service number

+44 (0) 800 917 8776

Get your accreditation

Optimize your accreditation efforts with BD AccrediWorld, the digital service where all documentation about BD solutions is in one place

Learn more

Deep dive into the BD MAX™ System

Get the most out of your BD MAX™ with our learning centre and webinars

How do other BD MAX™ users engage their platform?

How has NHS Chesterfield Royal Hospital optimized bed management?
April, 2019

“The major advantage of using the BD MAX in the laboratory, it’s a very easy system to use. It’s actually support staff driven, which means it takes away a lot of the specialist biomedical scientists”

Watch now

How did the BD MAX™ System help Bio 67 lab improve patient management?
April, 2019

“We found twice as many positive results as before that’s what makes the BD MAX™ solution unique: it’s incredibly sensitive as the results were confirmed in culture retrospectively so the screening was accurate and enabled us to deliver quick, relevant and trustworthy results.”

Watch now

Why join BD MAX™ Club?

Connect with professionals from around the world BD MAX™ Club members represent a community of professionals in infectious diseases and molecular diagnostics. With regional meet-ups and live webinars from global experts, expand your laboratory’s network and collaborate with worldwide colleagues.

Tailored medical and technical expertise Whether you need compelling scientific research or tutorials for troubleshooting on the BD MAX™ System, BD MAX™ Club is here to accompany your molecular diagnostics journey. Sign up now as a BD MAX Club member, to stay in the know of scientific updates and upcoming event(s).

Exclusive members’ perks BD MAX™ Club membership unlocks doors to exclusive webinars and collaboration with industry leading experts. Engage with your colleagues in the molecular community and exchange with the BD research and development team.

Forward Looking Statement

The information included on this website and other information provided from time to time through webcasts, conference calls, securities analyst meetings, road show presentations, investor conferences, newsletters and similar events and communications contains forward-looking statements (as defined under Federal securities laws) based on current expectations and assumptions that involve risks and uncertainties. If the risks or uncertainties ever materialize or the assumptions prove incorrect, the results of BD may differ materially from those expressed or implied by such forward-looking statements and assumptions. Forward-looking statements may be identified by the use of words such as “plan,” “expect,” “believe,” “intend,” “will,” “may,” “anticipate,” “estimate” and other words of similar meaning in conjunction with, among other things, discussions of future operations and financial performance (including volume growth, pricing, sales and earnings per share growth, and cash flows) and statements regarding our strategy for growth, future product development, regulatory approvals, competitive position and expenditures.

All such statements are based upon current expectations of BD and involve a number of business risks and uncertainties. Actual results could vary materially from anticipated results described, implied or projected in any forward-looking statement. Many of these risks and uncertainties are beyond the company’s control. For a discussion of certain factors that could cause our actual results to differ from our expectations in any forward-looking statements see our latest Annual Report on Form 10-K and other filings with the SEC. BD expressly disclaims any undertaking to update or revise any forward looking statements set forth herein to reflect events or circumstances after the date hereof, except as required by applicable law or regulation.